Your browser doesn't support javascript.
loading
Wilms tumour 1 peptide vaccine as a cure-oriented post-chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse.
Nakata, Jun; Nakae, Yoshiki; Kawakami, Manabu; Morimoto, Soyoko; Motooka, Daisuke; Hosen, Naoki; Fujiki, Fumihiro; Nakajima, Hiroko; Hasegawa, Kana; Nishida, Sumiyuki; Tsuboi, Akihiro; Oji, Yusuke; Oka, Yoshihiro; Kumanogoh, Atsushi; Sugiyama, Haruo.
Afiliação
  • Nakata J; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nakae Y; Department of Haematology, Kitano Hospital, Osaka, Japan.
  • Kawakami M; Department of Haematology, Nissay Hospital, Osaka, Japan.
  • Morimoto S; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Japan.
  • Motooka D; Department of Infection Metagenomics, Genome Information Research Centre, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Hosen N; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Fujiki F; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nakajima H; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Hasegawa K; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Nishida S; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Tsuboi A; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Japan.
  • Oji Y; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Oka Y; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Kumanogoh A; Department of Respiratory Medicine, Allergy and Rheumatic Disease, Osaka University Graduate School of Medicine, Suita, Japan.
  • Sugiyama H; Department of Immunopathology, Immunology Frontier Research Centre (World Premier International Research Centre), Osaka University, Suita, Japan.
Br J Haematol ; 182(2): 287-290, 2018 07.
Article em En | MEDLINE | ID: mdl-28542830
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Vacinas Anticâncer / Proteínas WT1 / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Vacinas Anticâncer / Proteínas WT1 / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article